# Ipilimumab (Genetical Recombination) I.V. Infusion 20mg (ヤーボイ点滴静注液２０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291430A2022). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291430A2022
- **Product name (Japanese):** ヤーボイ点滴静注液２０ｍｇ
- **English title:** Ipilimumab (Genetical Recombination) I.V. Infusion 20mg
- **Active ingredient:** イピリムマブ（遺伝子組換え）
- **Active ingredient (INN):** Ipilimumab (Genetical Recombination)
- **Strength / unit:** ２０ｍｇ４ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Bristol Myers Squibb (ブリストル・マイヤーズ スクイブ)
- **NHI price (reference only):** JPY 170598 per ２０ｍｇ４ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291430A2022
- **JSON:** https://www.nifujipharma.com/api/drugs/4291430A2022

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Ipilimumab%20(Genetical%20Recombination)%20I.V.%20Infusion%2020mg%20(%E3%83%A4%E3%83%BC%E3%83%9C%E3%82%A4%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E6%B6%B2%EF%BC%92%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291430A2022#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Ipilimumab (Genetical Recombination)

- [Ipilimumab (Genetical Recombination) I.V. Infusion 50mg (ヤーボイ点滴静注液５０ｍｇ)](https://www.nifujipharma.com/drugs/4291430A1026) — ５０ｍｇ１０ｍＬ１瓶, Bristol Myers Squibb